Antiphospholipid syndrome.
Arnout
Jef
J
University of Leuven, Leuven, Belgium.
Jankowski
Milosz
M
D017152:Antibodies, Antiphospholipid / Q000276:immunology; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000150:complications / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D001779:Blood Coagulation Factors / Q000378:metabolism; D003937:Diagnosis, Differential; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000276:immunology / Q000502:physiology; D008954:Models, Biological; D011516:Prothrombin / Q000276:immunology; D019851:Thrombophilia / Q000188:drug therapy / Q000209:etiology; D053482:beta 2-Glycoprotein I
D017152:Antibodies, Antiphospholipid; D001324:Autoantigens; D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents; D006023:Glycoproteins; D016682:Lupus Coagulation Inhibitor; D053482:beta 2-Glycoprotein I; D011516:Prothrombin